JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Incidence of vesicobullous and erosive disorders of neonates.

BACKGROUND: The entity vesicobullous disorders in neonates encompasses a varied spectrum of disorders varying from self limiting to potentially life threatening infectious diseases.

OBJECTIVE: To analyse the incidence of dermatoses in neonates, stress the importance of simple noninvasive diagnostic procedures with perspective to actual need of active intervention.

PATIENTS AND METHODS: Forty four neonates with vesicobullous lesions in departments of dermatology and pediatrics were evaluated with respect to diagnosis, required treatments and follow ups.

RESULTS: Out of total 44 neonates, 29 were males and 15 females. Iinfectious dermatoses accounted for: 9% - staphylococcal pyoderma, 4,5% - Group A Streptococcal impetigo, 4,5% - neonatal tinea faciei, 2,3% - neonatal candidiasis, 2,3% - neonatal varicella/chickenpox and 2,3% - scabies. Transient skin lesions were: 41% - erythema toxicum neonatorum, 9% - milia crystallina, 6.8% - neonatal acne, 4,5% - sucking blisters, 2,3% - transient neonatal pustular melanosis, 2,3% - epidermolysis bullosa simplex, 2,3% - incontinentia pigmentii, 2,3% - eosinophilic pustular folliculitis, 2,3% - pemphigus vulgaris and 2,3% - neonatal herpes simplex.

CONCLUSIONS: Care has to be instituted to identify accurately infectious diseases and distinguish them from benign transient neonatal dermatoses. Some disorders first manifesting during the neonatal period may also represent harbingers of potential problems during adulthood. Finally, it is relevant to judge whether the treatment is required or not.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app